Biotech: the EPO on the patentability of human embryonic stem cells
With a decision dated 4 February 2014 (Case T-2221/10), one of the EPO Boards of Appeal ruled on the highly debated issue of human stem cell patentability under the European Patent Convention (EPC). In particular, the board confirmed that human embryonic stem cell inventions are not patentable under article 53(a) of the EPC and clarified the technical and legal boundaries of such exclusion.
The board confirmed that, under the provisions of both article 53(a) and rule 28(c) of the EPC Implementing Regulation, any invention concerning and/or based upon human stem cells or stem cell lines and cultures that can only be obtained de novo via the prior destruction of human embryos are excluded from patentability due to their being ‘contrary to public order or morality’ and as they consist of ‘uses of human embryos for industrial or commercial purposes’…
Click on the link below to read the rest of the NCTM briefing.
News from NCTM
News from The Lawyer
Briefings from NCTM
Bankruptcy and liquidation trusts: under what conditions can they be recognised in the Italian legal system?
The Italian Supreme Court of Cassation has ruled that trusts can be recognised in Italy, when the settlor is insolvent, only if they are consistent with the purposes of the procedure.
A debtor in a concordato preventivo pre-filing regime can suspend but not terminate agreements pursuant to bankruptcy law
Can the Bankruptcy Court authorise the debtor to terminate credit facility agreements when the debtor submitted a pre-filing for concordato preventivo?
Analysis from The Lawyer
Being sent to London on secondment is a prized opportunity for associates in European firms